|
|
 |
|
Viewing report
|
|
|
|
Bioengineered Wound Care
Greystone Associates, Feb 2007, Pages: 90
A comprehensive assessment of the bioengineered wound care technologies and products for advanced wound management, this report provides a detailed analysis of twenty-two next-generation wound care products, including tissue-engineered skin substitutes, synthetic and harvested regeneration matrices, autologous grafts and biologically active cellular therapies. Management of chronic wounds and ulcers remains one of the most costly unsolved healthcare challenges. The report profiles companies active in bioengineered wound care therapeutics, and evaluates technology and business risk factors and market issues. This is a market that is experiencing unabated growth, as the aging of populations in developed countries leads to increasing caseloads of chronic wounds due to disease and immobility. With conditions such as diabetes, a major cause of skin ulcers, forecast to grow worldwide during the next fifteen years, demand for advanced wound care products and therapies will flourish. The report provides an easy-to-understand assessment of bioengineered wound care and the impact it will have on the advanced wound management segment of the healthcare industry.
Bioengineered Wound Care: Products, Players and Prospects is a comprehensive evaluation and analysis of the markets, products and participants in the technology-driven advanced wound management segment of the Healthcare sector.
Published in April (2005), the study is designed to provide market sector executives, business development professionals, product marketers, research managers, and healthcare decision makers with a detailed understanding of the market dynamics, business impact and therapeutic potential for bioengineered wound care products and technologies. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
New Tools and Treatments for Wound Management
The introduction of new technologies and products for the treatment of acute and chronic wounds is providing caregivers with a set of powerful options that will have a profound effect on the field of wound management. These new treatment tools, which mimic the body’s natural physiology and/or regenerative pathways, include tissue-engineered skin substitutes, regeneration matrices, and biologically active cellular therapies. First emerging as a viable treatment for refractory wounds in 1999, a number of products are currently available for certain indications, while others are in pre-clinical or clinical development.
These bioengineered products are competing in a worldwide market worth billions, and in which improvements in quality-of-life and treatment outcomes continue to be top healthcare industry initiatives. While pricing for these new-generation products represents a significant premium relative to existing wound care products, recent studies indicate their ability to promote healing in otherwise refractory wounds places them on a competitive plane in terms of total cost of treatment. As further data on patient outcomes becomes available, we expect the number of indications as well as third party payer acceptance of next-generation wound care products to increase, driving growth to significant levels by the middle of the decade.
Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks:
- Wound Care Market Assessment
- Economic Factors
- Bioengineered Wound Care Technology Analysis
- Company Profiles
- Product Status & Prospects
- Market Projections
- Industry Structure
- Strategic Alliances
- Development State Transition Factors
- Proprietary Technology
- Emerging Markets
- Market Factors
- Technology Factors
- Regulatory Factors
Methodology
Research methodology is based on primary research in tform of in-depth interviews with key market partitechnology developers, distributors, industry experts, and market influencers, a list that includes regulatory offiindustry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.
Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques
Feature Summary
-Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for treating acute and chronic wounds
-Assesses business risk factors and market issues
-Provides detailed analysis of twenty-two bioengineered wound care products
-Forecasts technology and product developments, and projects probable market impact through 2009
-Profiles bioengineered wound care companies, their product development activity, and strategies
-Evaluates the impact of economic, technology, and regulatory factors
Customers who bought this item also bought
Advanced Wound Management Markets in South Korea
Wound Care Products - Global Strategic Business Report
Chinese Markets for Baby Care Products
Chinese Markets for Laundry Care Products
U.S. Interactive Wound Care Markets
Toilet Care Products - United States
United States Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012
Eye Care in the USA
|
|
|
|
